Clinical Trial Update: Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating how PD 0332334 and metformin are eliminated when administered together, sponsored by Pfizer; the trial has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• PD 0332334
• metformin (metformin)

Snippet

Sponsor: Pfizer | Conditions: Generalized Anxiety Disorder | Phase 1 | Status: TERMINATED